Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, CSL commits to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Fly over the sparkling city of Tokyo in this video from Rare Disease Day Japan. On February 28, the Tokyo Tower sent a colorf…
Outnumbered by people with healthy immune systems, patients share COVID-19 pandemic perspectives in reports in The Philadelph…
She’s a scientist driven by CSL’s promise to patients – and she’s a cultural ambassador who introduced her Australian friends…
CSL Behring lit up Philadelphia’s Boathouse Row in celebration of Rare Disease Day and the rare disease patient community.
February 28 is an important day of the year for the rare disease community. How much do you know about it?
Around the world, more babies than ever are getting tested at birth for rare conditions, like SCID. But one of the world’s le…
Are you joining the Global Chain of Light for Rare Disease Day? Learn how to take part from home.
“My passion is technology,” says Ow, CSL’s Associate Director of Analytical Biochemistry. Based in Australia, he was born in …
Hear CSL CEO Paul Perreault’s answer in this one-minute video.
Americas
Asia Pacific
Middle East
Europe
